Reporting
Latest stories
Markets, companies and the economy, with the date and primary source attached.
Net Power closes EMPower EPC assignment for about 123 MW at Project Permian.
Aug. 31 close (AccNo 0001104659-26-105072): Saulsbury EPC Owner rights for ~123 MW Wärtsilä reciprocating capacity; ~$58.9M cash to EMPower; ~$97.6M Closing Date outlay — no PPA, no FID.
Albemarle names Ragnar Udd CEO effective February 1, 2027; Masters to Executive Chair.
Board-approved succession (8-K AccNo 0001140361-26-035623): Udd, 54, from BHP CCO; Masters transitions to Executive Chair/Chairman upon Udd joining; Steiner stays Lead Independent Director.
China's NMPA approved etripamil nasal spray for adult PSVT. Everest owes Milestone $2.0 million.
NMPA approved etripamil nasal spray for adult PSVT — Milestone's first etripamil approval outside the U.S. — triggering a $2.0M Everest milestone. U.S. CARDAMYST status is prior FDA approval as printed, not a new FDA action.
Nonfarm productivity rose 1.4% SAAR in Q2. Labor share hit a series low.
BLS (USDL 26-1434): Q2 2026 revised. Nonfarm productivity +1.4% SAAR (output +1.7%; hours +0.3%). ULC +1.2%. Labor share 52.8% — lowest since the series began in Q1 1947. Manufacturing productivity revised to +2.4%.
The July U.S. trade deficit widened to $88.6 billion.
Census and BEA (BEA 26-40 / CB 26-142): July goods-and-services deficit $88.6B, up $17.4B from revised June $71.2B. Exports $310.7B (-2.1%); imports $399.3B (+2.8%). Seasonally adjusted, not price-adjusted.
Akeso reported a China overall survival benefit for ivonescimab. It is not a U.S. approval.
Akeso's China HARMONi-2 Phase III showed a statistically significant OS gain for ivonescimab vs pembrolizumab in PD-L1-positive advanced NSCLC. OS HR not printed. Investigational in Summit territories. HARMONi PDUFA November 14, 2026.
Equity Bancshares agreed to buy Lincoln Bancorp for about $123.8 million.
The proposed Iowa bank merger is designed as roughly 77.5% EQBK stock and 22.5% cash, adds 16 Lincoln Savings Bank locations, and is expected to close in Q4 2026.
AbbVie closed its $10.9 billion Apogee Therapeutics acquisition.
Sept. 3, 2026 close: eligible APGE shares converted into $135.11 cash; Apogee Therapeutics became an indirect wholly owned AbbVie subsidiary and is leaving Nasdaq.
NVIDIA’s $11.9 billion Hugging Face deal aims for first-half 2027
Sept. 2, 2026 definitive agreement: NVIDIA to acquire Hugging Face for about $11.9 billion to stockholders (subject to adjustments), plus up to about $1.0 billion equity retention. Expected close: first half of 2027.
Diversified Energy’s ~$1.8 billion Birch Permian package targets a Q4 close
Sept. 2, 2026 definitive agreements: DEC to acquire Birch Permian from Elliott affiliates for ~$1.8B gross; ~$1.5B Carlyle ABS + revolver; expected Q4 2026 close.
Hillman closed Kanebridge for about $315 million.
Aug. 28, 2026 close: Hillman completed Kanebridge for ~$315M (customary adjustments); funded with cash, ABL draw, and new $200M TLB at SOFR+200.
Apogee’s GroGlass SPA: about €62.5 million CFDF, €10 million earnout cap
Sept. 2, 2026 SPA: Apogee to buy 100% of Alzette/GroGlass for ~€62.5M CFDF inclusive of contingent; €10M earnout cap over 3 years post-close; issuer ~$72.5M/~$11.6M at current FX; expected fiscal 2027 Q3.
$1.14 cash plus 0.1 share: GoPro’s Action Acquisitions merger still needs a vote
Sept. 1, 2026 GoPro–Action Acquisitions merger agreement: $1.14 cash + 0.1 surviving share per share (NWC may cut cash); Midtown Equities commitment; $10,000,000 fee; vote/HSR still required.
Broadcom’s $29.6 billion quarter is mostly an AI semiconductor story
Broadcom Q3 FY26 (ended Aug 2): net revenue $29.6 billion, +86% YoY from $15.95 billion. AI semis $16.7 billion (+221% YoY, +54% QoQ). Q4 revenue guide about $34.8 billion (+93%); Q4 AI semis expected $21.7 billion. Dividend $0.65.
Zaffino steps down as AIG Executive Chair. Rice becomes Chair. Andersen stays CEO.
Effective September 15, 2026, Peter Zaffino leaves AIG’s Executive Chair and board roles for a Senior Advisor post; John Rice, Lead Independent Director, becomes Chair. President & CEO Eric Andersen is unchanged on this filing.
Vertiv’s UIG deal: about $1.45 billion cash up front, up to $1.15 billion contingent
Vertiv signed a Sept. 1, 2026 merger agreement for UtilityInnovation Group: about $1.45 billion upfront cash at closing plus up to $1.15 billion contingent, with close aimed at Q4 2026.
John Ternus is Apple’s CEO. Tim Cook is still in the building as Executive Chair.
Effective September 1, 2026, John Ternus — longtime head of Hardware Engineering — is Apple’s chief executive and a board member. Tim Cook is Executive Chair. Arthur Levinson is Lead Independent Director. Apple’s leadership page lists those titles live. The Board appointed Ternus on April 17; Apple announced the plan on April 20.
Helix and Hornbeck closed all-stock. Legacy holders get 10.27167. HOS expected Sept. 2
The Helix–Hornbeck all-stock combination closed September 1, 2026. Legacy Hornbeck common converts at 10.27167. HLX ceases after the close. HOS is expected NYSE September 2. The 8-K Date of Report is August 28.
Vertex completes $85-a-share cash buyout of Crinetics
Vertex Pharmaceuticals completed its acquisition of Crinetics Pharmaceuticals on September 1, 2026. Holders get $85.00 a share in cash. Vertex puts the aggregate consideration at about $10.0 billion. The merger agreement was signed July 6. Crinetics asked Nasdaq to suspend CRNX trading before the open on the closing day.
Yum sold Pizza Hut. LongRange wrote the check. China was a different deal.
September 1, 2026: Yum! closed Pizza Hut Ex-China to LongRange for $1,488,000,000 cash. EX-99.1: $75 million earn-out opportunity by 2030; $2.7 billion aggregate with the August 7 Yum China close, subject to adjustments. Powell resigned.
GE Vernova names McDonough next CFO, effective January 1, 2027. Parks retires April 2.
GE Vernova named Claire McDonough next CFO effective Jan. 1, 2027. Parks remains CFO and retires April 2, 2027. Advisor to Strazik Nov. 1, 2026. Rivian last day Oct. 30, 2026. Rivian does not name GE Vernova.
ONEOK has a $4,425,000,000 Brazos deal, Class B, and tenders. None closed.
Aug. 18: $4,425,000,000 cash for Brazos Midland, HSR not cleared. Aug. 28: $9 billion Class B at HoldCo, not common stock. Aug. 31: tenders for 20 series; the 8-K is not an offer. None closed.
Solstice and Element Solutions mutually terminate. The $500 million is an authorization
The July 6 merger ended by mutual terminate on Aug. 27, not a close. Neither side pays a fee. Solstice authorized a $500 million buyback, not a spend, and affirmed 3Q and increased FY2026 guidance.
GameStop stopped the conversion clock. The rest is a $358 million check.
On Aug. 31 GameStop cut the 35-day stock window on a ~$1.4 billion convert exchange. Holders get about 55.5 million shares and about $358 million cash. Full Q2 is still September 8.
BioMarin and Ascendis settle Yuviwel patent cases on a 20% U.S. royalty
Binding term sheet Aug. 30: 20% of U.S. net sales and 18% in the EU, Brazil, and South Korea until May 2030. A settlement Agreement is supposed to replace the sheet by Sept. 24, 2026; if not, the sheet stays binding.